Sandoz US News

sandoz_us_news.jpg

Sandoz biosimilar filgrastim recommended for approval by FDA Oncologic Drugs Advisory Committee

Sandoz biosimilar filgrastim recommended for approval by FDA Oncologic Drugs Advisory Committee.

Phase III data shows Sandoz’ investigational biosimilar filgrastim has similar safety and efficacy as Amgen’s NEUPOGEN®

Phase III data shows Sandoz’ investigational biosimilar filgrastim has similar safety and efficacy as Amgen’s NEUPOGEN®

Sandoz launches first generic version of cyclophosphamide injection, USP

Princeton, New Jersey, November 7, 2014 – Sandoz today announced the US market introduction of cyclophosphamide injection, USP.

Sandoz Multimedia

Multimedia_Center_300x77.jpg

Visit our multimedia gallery to learn about Sandoz.

Product Catalog

Use our Product Catalog tool to search our database for information regarding a specific Sandoz product in the US.

Sandoz Careers

sandoz_careers.jpg

Our people are our greatest resource. We are always looking for new colleagues to share in our passion and commitment to making the world a healthier place.

Slideshow Background Images